These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 36068012)
1. METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8. Gong WJ; Li R; Dai QQ; Yu P J Gastroenterol Hepatol; 2022 Dec; 37(12):2229-2242. PubMed ID: 36068012 [TBL] [Abstract][Full Text] [Related]
2. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway. Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058 [TBL] [Abstract][Full Text] [Related]
3. METTL3 promotes IL-1β-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p. Xiao L; Zhao Q; Hu B; Wang J; Liu C; Xu H J Cell Mol Med; 2020 Dec; 24(23):14013-14025. PubMed ID: 33098220 [TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1. Bao J; Xu T; Wang W; Xu H; Chen X; Xia R Mol Cell Biochem; 2024 Nov; 479(11):3077-3089. PubMed ID: 38180718 [TBL] [Abstract][Full Text] [Related]
5. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression. Li S; Lu X; Zheng D; Chen W; Li Y; Li F J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010 [TBL] [Abstract][Full Text] [Related]
6. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway. Ye K; Li L; Wu B; Wang D Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer. Liang X; Zhang Z; Wang L; Zhang S; Ren L; Li S; Xu J; Lv S Bioengineered; 2021 Dec; 12(2):10023-10036. PubMed ID: 34666602 [TBL] [Abstract][Full Text] [Related]
8. Effect of miR-129-3p on autophagy of interstitial cells of Cajal in slow transit constipation through SCF C-kit signaling pathway. Wang H; Ren B; Pan J; Fu S; Liu C; Sun D Acta Biochim Pol; 2022 Sep; 69(3):579-586. PubMed ID: 36057985 [TBL] [Abstract][Full Text] [Related]
9. METTL3-mediated m6A modification promotes processing and maturation of Gong Y; Jiang Q; Liu L; Liao Q; Yu J; Xiang Z; Luo X Physiol Genomics; 2022 Sep; 54(9):337-349. PubMed ID: 35759451 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8. Zha X; Xi X; Fan X; Ma M; Zhang Y; Yang Y Aging (Albany NY); 2020 May; 12(9):8137-8150. PubMed ID: 32365051 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of METTL3-mediated m6A modification in depression-induced cognitive deficits. Niu J; Wang B; Wang T; Zhou T Am J Med Genet B Neuropsychiatr Genet; 2022 Apr; 189(3-4):86-99. PubMed ID: 35591810 [TBL] [Abstract][Full Text] [Related]
12. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940 [TBL] [Abstract][Full Text] [Related]
13. METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner. Zhang R; Qu Y; Ji Z; Hao C; Su Y; Yao Y; Zuo W; Chen X; Yang M; Ma G Cell Mol Biol Lett; 2022 Jul; 27(1):55. PubMed ID: 35836108 [TBL] [Abstract][Full Text] [Related]
14. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner. Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135 [TBL] [Abstract][Full Text] [Related]
16. miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer. Wu H; Li F; Zhu R Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):304-316. PubMed ID: 33355622 [TBL] [Abstract][Full Text] [Related]
17. METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer. Jing L; Lan L; Mingxin Z; Zhaofeng Z Sci Rep; 2022 Oct; 12(1):16715. PubMed ID: 36202872 [TBL] [Abstract][Full Text] [Related]
18. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP. Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729 [TBL] [Abstract][Full Text] [Related]
19. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway. Ma X; Ren H; Zhang Y; Wang B; Ma H Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241 [TBL] [Abstract][Full Text] [Related]
20. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway. Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]